A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon(Mayo Clinic), Brian G. Weinshenker(Mayo Clinic in Arizona), Claudia F. Lucchinetti(Mayo Clinic in Arizona), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Kazuo Fujihara(Tohoku University), Dean M. Wingerchuk(WinnMed), Sean J. Pittock(Mayo Clinic), Thomas J. Kryzer(Mayo Clinic)
Cited by 3,234
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k